Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Atox Bio

Atox Bio

A company developing immunomodulators to treat acute inflammatory conditions

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

December 19, 2011
Atox Bio raises a $3,250,000 series A round.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Atox Bio
Invalid Date
www.prnewswire.com:443
CHAPEL HILL, North Carolina and NESS ZIONA, Israel, Feb. 14, 2019 /PRNewswire/ -- Atox Bio, a clinical stage company developing novel therapies for critically...
Golden logo
By using this site, you agree to our Terms & Conditions.